However, in CCR9+ memory T cells, the expression of RORγt was specifically upregulated, and the production of IL-17A and IFN-γ was high in patients with secondary progressive MS (SPMS) compared to healthy controls, indicating the loss of regulatory function [33]. Here, IL17A is linked to secondary progressive multiple sclerosis.